KOLON Corporation

Kolon Pharma is a South Korean pharmaceutical company with a diversified portfolio of prescription drugs, over-the-counter medications, health functional foods, and an expanding pipeline of new drug candidates. The company has several approved products in Korea across pulmonology, dermatology, pediatrics, orthopedics, otorhinolaryngology, and other fields. Recent merger with Plat Bio has strengthened its capabilities in clinical translational research and anti-cancer drug development. Its pipeline spans from discovery to commercialized products; notable recent focus areas include idiopathic pulmonary fibrosis and liver disease.